CINIE CINIE
中文 | English | Français | Русский
Home CINIE World Nuclear Fusion Nuclear Application

Search Results

Keyword:¹⁷⁷Lu-edotreotide

ITM Receives Complete Response Letter from FDA for ¹⁷⁷Lu-edotreotide New Drug Application

ITM Receives Complete Response Letter from FDA for ¹⁷⁷Lu-edotreotide New Drug Application

Radiopharmaceutical biotechnology company ITM Isotope Technologies Munich SE (ITM) announced on August 10 that it had received a Complete Response Letter (CRL) from the U.S. Food and Drug Administration (FDA) on August 7, 2026, regarding the New Drug Application (NDA) for its investigational drug ¹⁷⁷Lu-edotreotide (ITM-11). The drug is intended for the treatment of gastroenteropancreatic neuroendocrine tumors (GEP-NETs).

2026-08-11

Reading Ranking

  • 1 South China Regional Office carries out supervision of core equipment at Changjiang Small Modular Reactor
  • 2 China's First Actinium-225 Mass Production Qualification Lands in Chongqing: SPIC Isotope Synergy Accelerates Breakthrough in High-End Medical Isotope Supply Chain Bottleneck
  • 3 U.S. NRC Accepts Construction Application for Blue Energy Project
  • 4 Iranian Atomic Energy Organization Official Says Domestically Built Fusion Device Will Be Commissioned
  • 5 Southwest Regional Office of the Ministry of Ecology and Environment Visits CNNC Sichuan Environmental Protection for Exchange
  • 6 France Releases Ten-Year Nuclear Fusion Energy Development Strategy Roadmap
  • 7 Zhongke Qingneng Wins Bid for DongSheng Fusion HOPE Device Cryogenic System
  • 8 Breakthrough in New Bacterial Imaging Agent Developed by UCSF
  • 9 Topological Fusion of Magnetic Mirror and Stellarator: How Fu Guoyong's Team's "Linked-Mirror" Deduces a New Engineering Pathway for Controlled Nuclear Fusion
  • 10 Singapore Enhances Nuclear Energy Assessment Capabilities Ahead of International Review
  • 11 Oklo Partners with U.S. Forged Rings to Reshape Domestic Nuclear Manufacturing
  • 12 Russia's Bureau 1440 tests satellite communications on nuclear icebreaker
  • 13 New York Power Authority Announces Shortlisted Developers for Nuclear Energy Project
  • 14 France's Newcleo Partners with US Curio to Advance Nuclear Fuel Recycling
  • 15 Saint Vincent and the Grenadines Hosts Nuclear Safeguards Workshop
CINIE

Organizing Committee of the Shenzhen Nuclear Expo

Telephone: +86 10-67808008

+86 10-68808008

Email: info@cinie.net

CINIE

Event Overview Support Services Highlights Archive Contact Us

World Nuclear

China Nuclear Power News World Nuclear Power News Expert Views Nuclear Power Technology

Fusion

China Fusion World Fusion Big Science Facilities ITER Program Business & Capital

Nuclear Application

Medical Scientific Research Environmental Protection Industry Food Agriculture Security
About us | All rights reserved
CINIE All rights reserved 2026 ICP License:京ICP备12027382号-9